Clinical Trials Browser

Phase 1 × Completed × Laryngeal Diseases × Clear all

Deglutition Disorders, Laryngeal Diseases, Laryngeal Neoplasms

NCT02586207 2025-10-07

Pembrolizumab in Combination With CRT for LA-SCCHN

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT02158234 2023-01-19

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Phase 1 Completed

20 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases

NCT01540682 2018-08-29

MLN8237 in Head and Neck Cancer

Phase 1 Completed

9 enrolled

Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases

NCT01208883 2014-01-24

A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer

Phase 1 Completed

10 enrolled

Head & Neck

Carcinoma, Squamous Cell, Laryngeal Diseases

Clinical Trials

The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement

Pembrolizumab in Combination With CRT for LA-SCCHN

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

MLN8237 in Head and Neck Cancer

A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer